Retatrutide is a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Research has focused on its effects on adipose-tissue pathway research, metabolic pathway research, and appetite signaling pathways. Phase 2 clinical trials have demonstrated significant effects on body weight and metabolic markers.
Retatrutideis provided as a lyophilized powder for reconstitution with bacteriostatic water prior to use in laboratory assays. Store lyophilized product at -20°C for long-term storage. Reconstituted solutions should be stored at 2-8°C and used within 30 days.
